TOP STORIES

• BUSINESS Two-Thirds of Drug Makers Discontent with FY2025 Price Revision: Survey
  March 11, 2025

• BUSINESS Drug Makers Weigh Withdrawal of Unprofitable Drugs, Generic and Innovative Players Alike: Poll
  March 11, 2025

• BUSINESS Japan Drug Makers See Varied Impact from 2025 Revision, Foreign Firms Take Hit: Poll
  March 10, 2025

• REGULATORY Stelara to Get 40.8% Price Cut on PMP Return, Januvia Over 26% in 2025 Revision
  March 10, 2025

• REGULATORY MHLW Unveils New List Prices for FY2025 Revision; Stelara, Januvia Hit by PMP Return
  March 7, 2025

• REGULATORY Takeda’s Livmarli, BMS’s Camzyos, and More Inch Closer to Japan Approval
  March 7, 2025

• ORGANIZATION Cough Drug Asverin Tops Supply Shortage Ranking in Japan: P-Cubed Survey
  March 6, 2025

• BUSINESS Unexpected Demand Triggers Supply Curb for Eisai’s ALS Med Just 3 Months after Launch; Patients Urge Early Response
  March 5, 2025

• BUSINESS Sumitomo Group Continues to Seek Best Partners for Pharma Biz
  March 5, 2025

• BUSINESS Japan Pharma Market Hits 11.5 Trillion Yen in 2024, Keytruda Wins Crown: IQVIA
  March 5, 2025

• COMMENTARY Evolving GLP-1 Drugs: Could Double and Triple Agonists Achieve Blockbuster Status?
  March 4, 2025

• BUSINESS 680 Employees Exit Takeda in Buyout Program, 10%-Plus of Japan Staff
  March 4, 2025

• REGULATORY No Prior Talks with US Drug Makers for Deferred PMP Price Cuts: Health Minister
  March 3, 2025

• REGULATORY J&J’s Lazcluze, Genmab’s Tivdak and More Drugs in Line for Japan Approval
  February 28, 2025

• ORGANIZATION JPMA President Demands Rethink of Social Security Expenditure Cap
  February 27, 2025

• ORGANIZATION Japan Pharma Lobbies Likely to Enter Yasukawa/Miyabashira Era toward FY2026 Reform
  February 26, 2025

• ACADEMIA 1st CP Inhibitor Approved for Sarcoma, Could This Be a Breakthrough to Treatment of More Subtypes?
  February 25, 2025

• REGULATORY Japan Approves CSL’s HAE Med Andembry, Tecentriq Sarcoma Use, and More
  February 21, 2025

• REGULATORY Pfizer Pulls Japan NDA for Hemophilia Gene Therapy Beqvez as Program Called Off Globally
  February 20, 2025

• BUSINESS LTL Pharma Sees 30% Drop in Gaster Sales after New LLP Coverage Rollout
  February 19, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• …
• Next ›
• 最終 »